PMDA — authorised 8 January 2019
- Marketing authorisation holder: Ono Pharmaceutical Co., Ltd.
- Status: approved
🇯🇵 Braftovi in Japan
PMDA authorised Braftovi on 8 January 2019
Marketing authorisation
Braftovi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Braftovi approved in Japan?
Yes. PMDA authorised it on 8 January 2019.
Who is the marketing authorisation holder for Braftovi in Japan?
Ono Pharmaceutical Co., Ltd. holds the Japanese marketing authorisation.